WO1995001292A1 - Packaging of enzymes - Google Patents

Packaging of enzymes Download PDF

Info

Publication number
WO1995001292A1
WO1995001292A1 PCT/EP1994/002151 EP9402151W WO9501292A1 WO 1995001292 A1 WO1995001292 A1 WO 1995001292A1 EP 9402151 W EP9402151 W EP 9402151W WO 9501292 A1 WO9501292 A1 WO 9501292A1
Authority
WO
WIPO (PCT)
Prior art keywords
bag
dispersion
enzyme
packaging
packed
Prior art date
Application number
PCT/EP1994/002151
Other languages
French (fr)
Inventor
Roland Cocker
Original Assignee
Quest International Bv.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest International Bv. filed Critical Quest International Bv.
Priority to AU70739/94A priority Critical patent/AU7073994A/en
Publication of WO1995001292A1 publication Critical patent/WO1995001292A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D77/00Packages formed by enclosing articles or materials in preformed containers, e.g. boxes, cartons, sacks or bags
    • B65D77/04Articles or materials enclosed in two or more containers disposed one within another
    • B65D77/06Liquids or semi-liquids or other materials or articles enclosed in flexible containers disposed within rigid containers

Definitions

  • the invention relates to a novel method for packaging enzyme solutions or dispersions as well as to the packaged enzymes themselves.
  • enzymes are offered for sale is in the form of a liquid. Since enzymes themselves are mainly solids, such enzymes may be dissolved or dispersed in a suitable liquid to obtain the enzymes in a liquid form. Other methods for obtaining enzymes in a liquid form may also be applied. Although a conventional liquid used for the preparation of such a solution or dispersion is water or an aqueous liquid, the invention may also be applied to enzymes dissolved or dispersed in other liquids. For the purpose of the invention, it is herein to be understood that “enzyme solutions” comprises all liquid forms of enzymes.
  • stabilizers and/or preservatives are generally added to the enzyme solutions to maintain enzymatic activity over a sufficient period of time.
  • preservatives are e.g. Na- benzoate, Na-sorbate, K-sorbate, Na-metabisulphite, and Na- parabens.
  • Enzyme stabilizers include salts (e.g. KC1, NaCl or sulphates) , humectants, proteins, amino acids, sugars and sugar alcohols, alcohols and polyols like glycerol. In some cases, the amount of stabilizer can be quite large.
  • the amount of glycerol can be up to 50% of the total volume of the stable enzyme solution. It will be clear that the use of stabilizers in this respect is considered to be inconvenient and burdensome.
  • the high volume of stabilizer to be used has a negative effect on the cost of packaging, storage and transport.
  • the concentration of the enzymes is limited as the product or mixture to which such a stabilized enzyme solution is added will be diluted thereby, which can be undesirable in some cases.
  • enzymes can be supplied without stabilizer and/or preservatives added thereto, or at least a reduced amount of one or more of these compounds. This applies especially to preserved enzymes which are to be used in foods or foods applications, since preservatives are generally considered as a chemical additive by the customer and the use of preservatives in foodstuffs has a negative image.
  • a so called (aseptic) bag-in-box type of packaging allows a decrease of the amount of stabiliser and/or preservative. Such a decrease may be that large that no substantial amount of stabiliser and/or preservative is needed for keeping the quality of the enzyme long enough within specification.
  • Such a type of packaging exists in many different varieties, but they all have in common that they comprise at least a flexible, liquid-tight container (e.g. made from a flexible plastic bag) with at least one opening for filling and emptying the container and a more or less rigid supportive member surrounding the flexible container.
  • a supportive member may be made of materials such as steel, wood, carton, cardbox, rigid plastic, etcetera. Different forms and shapes of the rigid supportive member are possible, and include box-shaped and cylinder shaped models.
  • the bag is preferably composed of a material which is impermeable for oxygen.
  • bag-in-box type containers as mentioned in the preceding paragraph are well known in the art for e.g. wine, milk and cream. They are used for such purposes to prevent microbial spoilage and oxidation of the liquid contained therein.
  • one embodiment of the invention is a packed enzyme solution or dispersion, characterized in that the enzyme solution or dispersion is contained in a bag-in-box type container.
  • the amount of stabilizer and/or preservative normally needed when using rigid containers can be reduced.
  • an enzyme solution packed according to the invention contains less than 30% by weight, preferably less than 10% by weight of a stabiliser.
  • shelf life stabilities one relating to a packed product which is not opened for use (period starts to run from date of packing the product) .
  • Another shelf life stability for a packed product relates to a shelf life stability for a product once the protective packaging material is opened (such a period starts to run from the first usage) .
  • the method of packaging according to the invention is suitable for all sorts of enzymes including proteases, peptidases, lipases, and carbohydrate modifying enzymes.
  • the method according to the invention works especially well with the carbohydrate modifying enzyme invertase, which used to comprise up to 50% of its volume of glycerol as a stabilizer. This can now be substantially reduced or even completely omitted.
  • bag-in-box as well as bag-only packaging is known for the packaging of enzyme containing liquid detergent compositions
  • these packed detergent compositions are not subject of this invention.
  • the invention applies to packaging enzyme solutions or dispersions wherein the enzyme is the main active component and not an additive, as in the case of e.g. detergent compositions.
  • solvents, carriers, diluents etc. are not considered to be main active components.
  • the bag-in-box type packaging as disclosed above is very well suitable to replace the conventional drum type of packaging.
  • An even more simple type of packaging can be achieved, however, for applications wherein the whole content of a container is used at once (i.e. one shot use or use. within one day) .
  • a simple bag can be used, preferably without the rigid supportive member and preferably even without complicated emptying valves.
  • the customer wishing to use e.g. 4 litres of an enzyme solution simply orders a 4 litre bag of the right enzyme solution, opens it and pours the total content in the equipment where the enzyme is needed.
  • the same decrease in stabilizer and/or preservative can be achieved.
  • the empty package remaining is environmentally friendly, and can simply be recycled or burned, without leaving any residual enzymes.
  • another embodiment of the invention is enzyme solutions or dispersions packed in a simple bag type container.
  • the same type of bags can be used as. in the bag- in-box type packaging. Similar advantages as for the bag- in-box type packaging w.r.t. the use of stabilizers and/or preservatives as well as to the pH of the solution apply for the bag-only type packaging as well.
  • bag-in-box containers Using the bag-in-box containers according to the invention as disclosed above enables the customer to dispense the enzyme, solution or dispersion from the container gradually, without the formation of headspace volume. This is a considerable advantage, since reactions in the headspace volume may cause microbial contamination or degradation by oxidation.
  • the bag By dispensing from a bag-in-box type container, the bag will simply collapse during emptying, and this can be achieved relatively easily without air entering the container.
  • the amount of stabilizer and/or preservative as discussed above can be reduced or substantially omitted by dispensing the enzyme solution from the bag-in-box type container.
  • a smaller bag size is used without decreasing the outer dimensions of the box. This can be achieved by loosely packing e.g. a 25 litre bag or multiple 25 litre bags in a larger container.
  • the containers may be designed to be convenient for automated handling, including palletised stacking and transport, since they all have the same outside dimension and shape, whilst the amount of enzyme to be packed is flexible and can be adjusted according to the wishes of the customer or producer of the enzyme.
  • the sterilized enzyme invertase, dissolved in water, without any additives was aseptically packed in four bag-in-box packs (size: 10 litres) . These bags were stored at room temperature for two months, and thereafter on subsequent days samples were taken from the packs. Two packs were stored at room temperature during sampling (samples 1 and 2) , and two were stored at ordinary refrigeration temperatures (about 4°C) during sampling (samples 3 and 4) . The samples were tested on TVC (Total Viable Count) , TE (Total Enterobacteria) , and Y + M (counts of yeast and moulds) . The results are set out in tables 1- 4. The results are also graphically displayed in figures 1 (samples 1 and 2) and 2 (samples 3 and 4) .
  • the enzyme invertase could be kept in good microbial condition: - before opening for at least two months during storage at room temperature, and - once opened for at least 3 days when stored at room temperature, and at least 18 days when stored at low temperature after opening.
  • storage stability was shorter than 1 day after opening. From this it can be concluded that the shelf life of a packed enzyme solution once it is opened is extended dramatically by using bag-in-box type packaging, which then allows a reduced level of stabilizers and/or preservatives. These stabilisers and/or preservatives may even be omitted in certain cases.

Abstract

By using bag-in-box type or bag-only containers instead of traditional drum-type containers for packaging it may be possible to reduce the amount of stabilizers and/or preservatives generally needed to maintain acceptable enzymatic activity of enzyme solutions or dispersions packed in drum type containers. This is probably due to aseptic and anaerobic packaging as well as to prevention of headspace volume formation.

Description

PACKAGING OF ENZYMES
The invention relates to a novel method for packaging enzyme solutions or dispersions as well as to the packaged enzymes themselves.
An important form in which enzymes are offered for sale is in the form of a liquid. Since enzymes themselves are mainly solids, such enzymes may be dissolved or dispersed in a suitable liquid to obtain the enzymes in a liquid form. Other methods for obtaining enzymes in a liquid form may also be applied. Although a conventional liquid used for the preparation of such a solution or dispersion is water or an aqueous liquid, the invention may also be applied to enzymes dissolved or dispersed in other liquids. For the purpose of the invention, it is herein to be understood that "enzyme solutions" comprises all liquid forms of enzymes.
Since most enzymes are degraded rapidly by microbial spoilage and/or by the influence of oxidizing compounds such as air, stabilizers and/or preservatives (antimicrobial compounds) are generally added to the enzyme solutions to maintain enzymatic activity over a sufficient period of time. Examples of preservatives are e.g. Na- benzoate, Na-sorbate, K-sorbate, Na-metabisulphite, and Na- parabens. Enzyme stabilizers include salts (e.g. KC1, NaCl or sulphates) , humectants, proteins, amino acids, sugars and sugar alcohols, alcohols and polyols like glycerol. In some cases, the amount of stabilizer can be quite large. When for example glycerol is used as a stabilizer for the enzyme" invertase, the amount of glycerol can be up to 50% of the total volume of the stable enzyme solution. It will be clear that the use of stabilizers in this respect is considered to be inconvenient and burdensome. The high volume of stabilizer to be used has a negative effect on the cost of packaging, storage and transport. Furthermore, the concentration of the enzymes is limited as the product or mixture to which such a stabilized enzyme solution is added will be diluted thereby, which can be undesirable in some cases.
An additional disadvantage that applies both for preservatives and stabilizers is that they will not always be compatible with the products or mixtures to which the enzymes are to be added. An even further disadvantage is that due to the need to use stabilizers (and in many cases quite substantial amounts) and/or preservatives the price of the enzymes per unit activity will go up.
Additionally, it is desired more and more by the enzyme users that enzymes can be supplied without stabilizer and/or preservatives added thereto, or at least a reduced amount of one or more of these compounds. This applies especially to preserved enzymes which are to be used in foods or foods applications, since preservatives are generally considered as a chemical additive by the customer and the use of preservatives in foodstuffs has a negative image.
The disadvantages listed above indicate that there is a need for packed, easy to use enzymes with a reduced amount of stabilizer and/or preservative, and more preferably, without any substantial amount of stabilizer and or preservative added thereto at all.
It has now been found that these objectives can be met by using a so called (aseptic) bag-in-box type of packaging. This type of packaging allows a decrease of the amount of stabiliser and/or preservative. Such a decrease may be that large that no substantial amount of stabiliser and/or preservative is needed for keeping the quality of the enzyme long enough within specification. Such a type of packaging exists in many different varieties, but they all have in common that they comprise at least a flexible, liquid-tight container (e.g. made from a flexible plastic bag) with at least one opening for filling and emptying the container and a more or less rigid supportive member surrounding the flexible container. Such a supportive member may be made of materials such as steel, wood, carton, cardbox, rigid plastic, etcetera. Different forms and shapes of the rigid supportive member are possible, and include box-shaped and cylinder shaped models. The bag is preferably composed of a material which is impermeable for oxygen.
The bag-in-box type containers as mentioned in the preceding paragraph are well known in the art for e.g. wine, milk and cream. They are used for such purposes to prevent microbial spoilage and oxidation of the liquid contained therein.
Previously, it was not thought possible to reduce or even omit stabilisers and or preservatives when storing enzyme solutions, unless one accepts a short shelf life stability when unopened, and an even shorter shelf life once opened. For example, in WO 88/03900 bag-in-box type packaging is suggested for enzymes, but it is mentioned that such an enzyme still contains glycerol, which is a well known enzyme stabiliser. Thus, one concludes that reducing the amount of stabilizer and or preservative when packing enzymes is not possible up till now, let alone omitting them.
Prevention of microbial spoilage and oxidation of enzyme solutions can be well achieved by conventional means (i.e. stabilizers and/or preservatives) , but what could not be achieved in the packaging of enzyme solutions up till now is a reduction of the amount of stabilizers and/or preservatives used. In the present invention, for some enzymes the stabilizers and/or preservatives can even be substantially left out, whilst the enzymatic activity is well maintained. By using a bag-in-box type packaging, it is possible to keep the enzyme solution in an anaerobic, aseptic way for a prolonged time.
Thus, one embodiment of the invention is a packed enzyme solution or dispersion, characterized in that the enzyme solution or dispersion is contained in a bag-in-box type container. In many cases, the amount of stabilizer and/or preservative normally needed when using rigid containers can be reduced. Preferably, an enzyme solution packed according to the invention contains less than 30% by weight, preferably less than 10% by weight of a stabiliser.
For some purposes, substantially no stabilizer and/or preservative at all will be needed in the packed enzyme solution according to the invention. This is of course the most preferred embodiment.
It may also be possible to eliminate the need for reducing the pH value to 4.5 or below, which is another method of avoiding microbial contamination.
One can distinguish two different shelf life stabilities: one relating to a packed product which is not opened for use (period starts to run from date of packing the product) . Another shelf life stability for a packed product relates to a shelf life stability for a product once the protective packaging material is opened (such a period starts to run from the first usage) .
The method of packaging according to the invention is suitable for all sorts of enzymes including proteases, peptidases, lipases, and carbohydrate modifying enzymes. The method according to the invention works especially well with the carbohydrate modifying enzyme invertase, which used to comprise up to 50% of its volume of glycerol as a stabilizer. This can now be substantially reduced or even completely omitted.
Although bag-in-box as well as bag-only packaging is known for the packaging of enzyme containing liquid detergent compositions, these packed detergent compositions are not subject of this invention. The invention applies to packaging enzyme solutions or dispersions wherein the enzyme is the main active component and not an additive, as in the case of e.g. detergent compositions. In this respect, solvents, carriers, diluents etc. are not considered to be main active components.
The bag-in-box type packaging as disclosed above is very well suitable to replace the conventional drum type of packaging. An even more simple type of packaging can be achieved, however, for applications wherein the whole content of a container is used at once (i.e. one shot use or use. within one day) . Herein a simple bag can be used, preferably without the rigid supportive member and preferably even without complicated emptying valves. The customer wishing to use e.g. 4 litres of an enzyme solution simply orders a 4 litre bag of the right enzyme solution, opens it and pours the total content in the equipment where the enzyme is needed. For this type of packaging the same decrease in stabilizer and/or preservative can be achieved. The empty package remaining is environmentally friendly, and can simply be recycled or burned, without leaving any residual enzymes. When using the conventional drum type packaging, such drums have to be cleaned, either by the customer or by the supplier (in the case of return drums) , which increases costs and risk of contamination of the environment with residual enzymes as well as the risk of formation of hazardous aerosols. Therefore, another embodiment of the invention is enzyme solutions or dispersions packed in a simple bag type container. The same type of bags can be used as. in the bag- in-box type packaging. Similar advantages as for the bag- in-box type packaging w.r.t. the use of stabilizers and/or preservatives as well as to the pH of the solution apply for the bag-only type packaging as well.
Using the bag-in-box containers according to the invention as disclosed above enables the customer to dispense the enzyme, solution or dispersion from the container gradually, without the formation of headspace volume. This is a considerable advantage, since reactions in the headspace volume may cause microbial contamination or degradation by oxidation. By dispensing from a bag-in-box type container, the bag will simply collapse during emptying, and this can be achieved relatively easily without air entering the container. Thus, the amount of stabilizer and/or preservative as discussed above can be reduced or substantially omitted by dispensing the enzyme solution from the bag-in-box type container. By dispensing in that way, it may additionally be possible to have a pH value of the enzyme solution of more than 4.5.
Apart from adding stabilizers, preservatives and humectants another method employed up till now to improve the keeping qualities of enzyme solutions and dispersions over time was cooling/refrigeration. By using the aseptic bag-in-box or bag-only packaging method according to the present invention such refrigeration may be omitted, although for some purposes (depending on e.g. the enzyme involved and the time interval between opening and emptying the bag-in- box pack) a combination of bag-in-box packaging and refrigeration may still be employed. This may even strongly enhance the extension of shelf life, both before and after opening the packaging material. When using bag-in-box packaging, the bag, when filled with enzyme (solution) , may completely occupy all space available in the rigid box. For some purposes, however, it may be preferred that a smaller bag size is used without decreasing the outer dimensions of the box. This can be achieved by loosely packing e.g. a 25 litre bag or multiple 25 litre bags in a larger container. By doing so, the containers may be designed to be convenient for automated handling, including palletised stacking and transport, since they all have the same outside dimension and shape, whilst the amount of enzyme to be packed is flexible and can be adjusted according to the wishes of the customer or producer of the enzyme.
The invention is illustrated by the following examples but is in no way limited thereto.
In the examples the sterilized enzyme invertase, dissolved in water, without any additives was aseptically packed in four bag-in-box packs (size: 10 litres) . These bags were stored at room temperature for two months, and thereafter on subsequent days samples were taken from the packs. Two packs were stored at room temperature during sampling (samples 1 and 2) , and two were stored at ordinary refrigeration temperatures (about 4°C) during sampling (samples 3 and 4) . The samples were tested on TVC (Total Viable Count) , TE (Total Enterobacteria) , and Y + M (counts of yeast and moulds) . The results are set out in tables 1- 4. The results are also graphically displayed in figures 1 (samples 1 and 2) and 2 (samples 3 and 4) .
From the results it can be concluded that by using the bag- in-box type packaging method according to the invention the enzyme invertase could be kept in good microbial condition: - before opening for at least two months during storage at room temperature, and - once opened for at least 3 days when stored at room temperature, and at least 18 days when stored at low temperature after opening. When the same invertase solution was kept and distributed from an ordinary container, storage stability was shorter than 1 day after opening. From this it can be concluded that the shelf life of a packed enzyme solution once it is opened is extended dramatically by using bag-in-box type packaging, which then allows a reduced level of stabilizers and/or preservatives. These stabilisers and/or preservatives may even be omitted in certain cases.
Figure imgf000010_0001
Figure imgf000011_0001
Figure imgf000012_0001

Claims

1. Packed enzyme solution or dispersion contained in a bag type container or a bag-in-box type container, characterized in that the solution or dispersion comprises less than 30% by weight of stabilizer.
2. Packed enzyme solution or dispersion according to claim 1, characterized in that the solution or dispersion comprises less than 10% by weight of stabilizer.
3. Packed enzyme solution or dispersion according to claim 1-2, characterized in that substantially no stabilizer is present in the container.
4. Packed enzyme solution or dispersion contained in a bag type container or a bag-in-box type container, characterized in that substantially no -preservative is present in the container.
5. Packed enzyme solution or dispersion contained in a bag type container or a bag-in-box type container, characterized in that the pH value of the solution or dispersion is higher than 4.5.
6. Packed enzyme solution or dispersion according to claim 1-5, characterized in that the enzymes comprises a carbohydrate modifying enzyme.
7. Packed enzyme solution or dispersion according to claim 6, characterized in that the carbohydrate modifying enzyme comprises an enzyme having invertase activity.
8. Method for dispensing an enzyme solution or dispersion from a container characterized in that it is dispensed from a flexible container without the formation of headspace volume.
9. Method according to claim 8, characterized in that the enzyme solution or dispersion is dispensed from a bag- in-box type container.
10. A method according to claim 8-9, wherein the enzyme solution or dispersion is substantially free from stabilizers.
11. A method according to claim 8-10, wherein the enzyme solution or dispersion is substantially free from preservatives.
12. A method according to claim 8-11, characterized in that the pH value of the solution or dispersion is larger that 4.5.
PCT/EP1994/002151 1993-07-02 1994-06-30 Packaging of enzymes WO1995001292A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU70739/94A AU7073994A (en) 1993-07-02 1994-06-30 Packaging of enzymes

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP93201939 1993-07-02
EP93201939.1 1993-07-02
EP93203282 1993-11-24
EP93203282.4 1993-11-24

Publications (1)

Publication Number Publication Date
WO1995001292A1 true WO1995001292A1 (en) 1995-01-12

Family

ID=26133892

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1994/002151 WO1995001292A1 (en) 1993-07-02 1994-06-30 Packaging of enzymes

Country Status (2)

Country Link
AU (1) AU7073994A (en)
WO (1) WO1995001292A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5988167A (en) * 1997-05-02 1999-11-23 Kamen; Jack M. Foam cuff for laryngeal mask airway
US7618800B2 (en) * 2002-09-10 2009-11-17 Toyo Boseki Kabushiki Kaisha Glycerol kinase, which has high resistance against preservative

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809032B2 (en) * 1977-03-02 1979-06-21 Olympus Optical Co., Ltd., Tokio Device for supplying a nutrient, buffer or enzyme solution for an automatic incubator
WO1988003900A1 (en) * 1986-11-25 1988-06-02 Life Technologies, Inc. Stak-pak liquid container delivery and storage system
EP0280665A1 (en) * 1987-02-17 1988-08-31 AB AKERLUND & RAUSING A method and a device for contamination free access to the contents of a packaging container
EP0297860A1 (en) * 1987-07-01 1989-01-04 Genentech, Inc. Method and therapeutic compositions for the prevention of fibrin deposition or adhesions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809032B2 (en) * 1977-03-02 1979-06-21 Olympus Optical Co., Ltd., Tokio Device for supplying a nutrient, buffer or enzyme solution for an automatic incubator
WO1988003900A1 (en) * 1986-11-25 1988-06-02 Life Technologies, Inc. Stak-pak liquid container delivery and storage system
EP0280665A1 (en) * 1987-02-17 1988-08-31 AB AKERLUND & RAUSING A method and a device for contamination free access to the contents of a packaging container
EP0297860A1 (en) * 1987-07-01 1989-01-04 Genentech, Inc. Method and therapeutic compositions for the prevention of fibrin deposition or adhesions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5988167A (en) * 1997-05-02 1999-11-23 Kamen; Jack M. Foam cuff for laryngeal mask airway
US7618800B2 (en) * 2002-09-10 2009-11-17 Toyo Boseki Kabushiki Kaisha Glycerol kinase, which has high resistance against preservative

Also Published As

Publication number Publication date
AU7073994A (en) 1995-01-24

Similar Documents

Publication Publication Date Title
Coles et al. Food and beverage packaging technology
Singh et al. Active packaging of food products: recent trends
US3198636A (en) Preservation of wine
US20090269324A1 (en) Antimicrobial peracid compositions with selected catalase enzymes and methods of use in aseptic packaging
US20120232154A1 (en) Preservatives based on carboxylic anhydrides
US5716811A (en) Stabilization of cultured skim milk bactericidal activity
US10426161B2 (en) Solid antimicrobial compositions with enhanced solubility
KR102554088B1 (en) Oxygen-scavenging polymer composition
CN104829930B (en) A kind of preparation method and applications of bacteriostasis, preservation packing film
Rejeesh et al. Packaging of milk and dairy products: Approaches to sustainable packaging
Singh et al. Damage reduction to food products during transportation and handling
Gonçalves et al. Safety and quality of antimicrobial packaging applied to seafood
WO1995001292A1 (en) Packaging of enzymes
CN106742766A (en) A kind of persimmon preserves retail air-adjustable fresh-keeping bag and its application
Yaris et al. Food Packaging-Glass and Plastic
WO2000063092A1 (en) Packing container and packing method
US3860729A (en) Preservation of beverages with poly(hexamethylenebiguanide hydrochloride)
EP1065144B1 (en) Method for packaging mussels and similar shellfish, and thus obtained package with shellfish
EP0785891B1 (en) Inhibition of the growth of micro-organisms
Mtolo et al. 14 Food packaging and packaging innovations
CA2894929A1 (en) Method of improving microbiological stability in a still water-based beverage and microbiologically shelf-stable still water-based beverages
WO2003084820A2 (en) Method for protecting packed food products from spoilage during storage and package or pre-cut package for storing food products
US9145518B2 (en) Stabilization of pyrocarbonic acid diesters by finely divided solids
SU232187A1 (en) ANTIOXIDATIVE COMPOSITION FOR STORAGE OF DRY POOR PRODUCTS
US3751264A (en) Preservation of beer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB GE HU JP KE KG KP KR KZ LK LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA